Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision v3.6.3 was added and v3.6.0 was removed in the study's documents section, updating the referenced protocol/SAP version for the trial record.
    Difference
    0.0%
    Check dated 2026-06-30T00:58:36.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The study details page now signals that recruitment is closed, and new help/navigation sections were added or revised (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading; a new revision version (v3.6.0) is shown.
    Difference
    0.1%
    Check dated 2026-06-15T19:16:41.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The revision label on the page footer updated from v3.5.4 to v3.5.5, indicating a deployment update; it represents a backend update with no visible edits to study information.
    Difference
    0.0%
    Check dated 2026-06-08T16:54:08.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4. This signals an updated version of the page content for the study record.
    Difference
    0.0%
    Check dated 2026-05-18T13:15:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page’s footer was updated to reflect a new ClinicalTrials.gov interface/revision version (v3.5.3 instead of v3.5.2). This is a platform/version display change rather than a change to the trial information.
    Difference
    0.0%
    Check dated 2026-04-27T07:36:19.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added Temuco (Araucania) and Viña del Mar (Valparaiso) as Chilean sites and removed the 'Región de' prefixes to standardize regional names.
    Difference
    0.3%
    Check dated 2026-04-20T02:32:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.